Saturday, May 2, 2026

Orient Cement Q4 net profit rises 32% despite revenue decline; declares dividend

Date:

Adani group firm Orient Cement Ltd on Tuesday (April 28) reported a 31.7% rise in fourth-quarter net profit at ₹55.4 crore compared with ₹42.1 crore in the year-ago period.Revenue for the quarter declined 21.6% to ₹647.2 crore from ₹825.2 crore in the corresponding period last year.


EBITDA rose 4.6% to ₹108 crore in the March quarter, compared with ₹103 crore a year earlier. EBITDA margin stood at 16.7% versus 12.5% in the same quarter last year.
Also Read: Orient Cement Q3 profit jumps nearly 3x on higher EBITDA, margins expandThe board of directors has recommended a dividend of ₹0.50 per equity share of face value ₹1 each, equivalent to 50%, for the financial year 2025-26, subject to the approval of shareholders.

The company has fixed Friday, June 12, 2026, as the record date for determining the entitlement of members to receive the dividend for FY26. If approved by shareholders at the ensuing annual general meeting, the dividend will be paid on or after Wednesday, July 1, 2026, subject to applicable tax deducted at source.

Shares of Orient Cement Ltd ended at ₹147.55, down by ₹0.40, or 0.27%, on the BSE.

Also Read: ‘Overhang removed’, say analysts after ACC-Ambuja-Orient Cement merger

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Vedanta Demerger: Two important triggers that keep the stock in focus today

Shares of Vedanta Ltd., the Anil Agarwal-owned mining conglomerate,...

EPFO updates: Key changes and new rules for employees’ provident fund subscribers in 2026

कर्मचारी भविष्य निधि संगठन (ईपीएफओ) ने पिछले कुछ महीनों...

Who are Lorna Hajdini and Chirayu Rana in lawsuit JPMorgan says lacks merit

Lorna Hajdini, a senior executive at JPMorgan Chase, has...

Stock Crash: Cancer drug developer shares plunge 48% after patient dies

Shares of Erasca Inc., a cancer-drug developer, fell as...